Home
News
Create
Screeners
Insights
Brawn Biotech
20.
11
-20.11
(-100.00%)
Market Cap
₹5.80 Cr
PE Ratio
31.40
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-100.00%
1M
-100.00%
6M
-100.00%
1Y
-100.00%
5Y
-100.00%
View Company Insights
Latest news about Brawn Biotech
Brawn Biotech Shareholders Approve Key Resolutions at 40th AGM
Sep 30, 2025
Brawn Biotech Limited held its 40th Annual General Meeting on September 30, 2025, via video conferencing. Shareholders approved several important resolutions including the re-appointment of Mr. Amit Kumar as Manager for a five-year term, adoption of a new Memorandum of Association, approval of financial statements, and re-appointment of Mrs. Brij Bala Gupta as director. All resolutions received overwhelming support with 99.99% votes in favor. The meeting, chaired by Mr. Brij Raj Gupta, lasted from 11:00 AM to 11:13 AM, with e-voting open for an additional 30 minutes.
Brawn Biotech Reports Turnaround with Rs 23.60 Lacs Profit in Q1
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation